Capivasertib
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-15431-5MG | 5 mg | 135,00 | Add | |
| HY-15431-1ML | 10mM/1mL | 147,00 | Add | |
| HY-15431-10MG | 10 mg | 196,00 | Add | |
| HY-15431-50MG | 50 mg | 469,00 | Add | |
| HY-15431-100MG | 100 mg | 621,00 | Add | |
| HY-15431-500MG | 500 mg | 1'851,00 | Add | |
| HY-15431-1G | 1 g | 2'801,00 | Add | |
| HY-15431-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Capivasertib (AZD5363) is an orally active and potent pan-AKT kinase inhibitor with IC50 of 3, 7 and 7 nM for Akt1,Akt2 and Akt3, respectively.
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Autophagy,PI3K/Akt/mTOR |
| Format | Solubility: DMSO : 125 mg/mL (ultrasonic) |
| Grade | Clinical information: Launched |
| Purity | 99.95% |
| Molecular Formula | C21H25ClN6O2 |
| Molecular Weight | 428.92 |
| CAS-Number | 1143532-39-1 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
